IGI Laboratories, Inc. announced that Stephen Richardson has been appointed Chief Scientific Officer (CSO) of IGI Laboratories, Inc. effective October 5, 2015. Steve brings almost 30 years, of experience in the specialty pharmaceutical industry, with a particular focus on generics. Most recently, Steve was a Principal Consultant for Lachman Consultant Services, Inc., where he provided expert compliance, regulatory affairs and technical services to many leading pharmaceutical and financial clients around the world.

Prior to Lachman, Steve served in various senior leadership roles, most recently as the VP of Scientific and Regulatory Affairs at JHP Pharmaceuticals, LLC.Steve was at JHP since 2007, and was an integral founding member of the Executive Management team, where he had direct responsibility of a team of thirty-five employees in both Regulatory and Medical Affairs, as well as Product Development.